Habib Bennaceur: New Perspectives on Patient-Centered Hemophilia Care at ISTH 2026
Habib Bennaceur, Senior Vice President of Rare Disease Unit at Novo Nordisk, shared a post on LinkedIn:
“Today I’m excited to be on the ground at ISTH in Paris – one of the most important moments in the haematology calendar, and a valuable opportunity to connect across the rare blood disorder space – with those living with these conditions, as well as colleagues, clinicians, nurses, and other community members.
What I value most about this congress is the energy around our shared sense of purpose.
For ISTH 2026, we’re presenting our own breadth of haemophilia data spanning ages and indications while also learning from the research and perspectives of others who are also exploring ways to deliver more and better for this community.
Despite significant progress, we know that people living with haemophilia still face daily trade-offs between protection from bleeds and the burden of treatment.
Alongside this is the mental load of managing that daily balance – something that is too often overlooked.
Challenging that reality is what continues to drive our passion and focus in this space.
At Novo Nordisk, we recognize that innovation in haemophilia is not only about preventing bleeds.
Our ambition is to give people genuine choice through options that fit within their real lives and reflect their individual needs.
For more than four decades, we have worked alongside this community; listening to their experiences, advancing the science, and deepening our understanding of what it means to live – and live well – with a rare bleeding disorder.
If you’re here in Paris, I encourage you to visit us at booth 907 and connect with our team.
I’m looking forward to the conversations ahead.”
Stay updated with Hemostasis Today.
-
Jul 11, 2026, 09:01Nathan Connell: Celebrating 100 Years of von Willebrand Disease at ISTH 2026
-
Jul 11, 2026, 08:50Heghine Khachatryan: Multidisciplinary PERTs Transform Pulmonary Embolism Care
-
Jul 11, 2026, 08:37Alejandro González Veliz: Key Takeaways from the 2026 ACC Scientific Statement on Antiplatelet Therapy
-
Jul 11, 2026, 08:35Rono Chonginio: The Power of Visual Storytelling in Healthcare and Non-Profits
-
Jul 11, 2026, 08:35Mavis Agnes Kisakye: Why Patient Identification Begins with an Informed Community
-
Jul 11, 2026, 08:35Leslie Lake: Compression Therapy in Venous Thromboembolism
-
Jul 10, 2026, 22:43Marignima Bennett: Grady Health System Earns the Highest Recognition for Excellence in Stroke Care
-
Jul 10, 2026, 21:31Robert Hamilton: Join NeuraSignal’s Webinar on Real-World Implementation of Robotic TCD in Stroke Care
-
Jul 10, 2026, 20:47New Machine Learning Models Improve Prediction of Thrombosis and Bleeding in Cancer – JTH